Search research articles
Contact Us
Filters
Showing results (231-240 of 325) with videos related to
Page
of 33
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
September 1, 1979
Cyclophosphamide/X-ray: combined mode preparation for transplantation therapy
R Meredith, J OKunewick, R Shadduck, et al.
Physiological Research
|
March 16, 2013
Hearing function in heterozygous carriers of a pathogenic GJB2 gene mutation
D Groh, P Seeman, M Jilek, et al.
Neurochemistry International
|
May 25, 2010
Characterization of brain D(2) dopamine receptors
L Lilly, A Davis, C M Fraser, et al.
Journal of Neurology
|
May 1, 2008
Extending the clinical spectrum of SPG3A mutations to a very severe and very early complicated phenotype
J Haberlová, K G Claeys, J Zámecník, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 1, 1989
Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain
P Seeman, H B Niznik, H C Guan, et al.
The British Journal of Psychiatry. Supplement
|
December 1, 1993
Dopamine receptors and antipsychotic drug response
R K Sunahara, P Seeman, H H Van Tol, et al.
Annals of Human Genetics
|
January 11, 2005
Double heterozygosity with mutations involving both the GJB2 and GJB6 genes is a possible, but very rare, cause of congenital deafness in the Czech population
P Seeman, O Bendová, D Rasková, et al.
International Journal of Molecular Medicine
|
September 22, 2000
Charcot-Marie-Tooth disease type 1A (CMT1A) and hereditary neuropathy with liability to pressure palsies (HNPP): reliable detection of the CMT1A duplication and HNPP deletion using 8 microsatellite markers in 2 multiplex PCRs
P Seeman, R Mazanec, J Zidar, et al.
Nature
|
August 31, 1978
Binding of 3H-neuroleptics and 3H-apomorphine in schizophrenic brains
T Lee, P Seeman, W W Tourtellotte, et al.
The Journal of Allergy and Clinical Immunology
|
May 10, 2001
Idiopathic environmental intolerance: increased prevalence of panic disorder-associated cholecystokinin B receptor allele 7
K Binkley, N King, N Poonai, et al.
Page
of 33
Search research articles
Search
Showing results (231-240 of 325) with videos related to
Sort By:
Page
of 33
International Journal of Radiation Oncology, Biology, Physics
|
September 1, 1979
Cyclophosphamide/X-ray: combined mode preparation for transplantation therapy
R Meredith, J OKunewick, R Shadduck, et al.
Physiological Research
|
March 16, 2013
Hearing function in heterozygous carriers of a pathogenic GJB2 gene mutation
D Groh, P Seeman, M Jilek, et al.
Neurochemistry International
|
May 25, 2010
Characterization of brain D(2) dopamine receptors
L Lilly, A Davis, C M Fraser, et al.
Journal of Neurology
|
May 1, 2008
Extending the clinical spectrum of SPG3A mutations to a very severe and very early complicated phenotype
J Haberlová, K G Claeys, J Zámecník, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 1, 1989
Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain
P Seeman, H B Niznik, H C Guan, et al.
The British Journal of Psychiatry. Supplement
|
December 1, 1993
Dopamine receptors and antipsychotic drug response
R K Sunahara, P Seeman, H H Van Tol, et al.
Annals of Human Genetics
|
January 11, 2005
Double heterozygosity with mutations involving both the GJB2 and GJB6 genes is a possible, but very rare, cause of congenital deafness in the Czech population
P Seeman, O Bendová, D Rasková, et al.
International Journal of Molecular Medicine
|
September 22, 2000
Charcot-Marie-Tooth disease type 1A (CMT1A) and hereditary neuropathy with liability to pressure palsies (HNPP): reliable detection of the CMT1A duplication and HNPP deletion using 8 microsatellite markers in 2 multiplex PCRs
P Seeman, R Mazanec, J Zidar, et al.
Nature
|
August 31, 1978
Binding of 3H-neuroleptics and 3H-apomorphine in schizophrenic brains
T Lee, P Seeman, W W Tourtellotte, et al.
The Journal of Allergy and Clinical Immunology
|
May 10, 2001
Idiopathic environmental intolerance: increased prevalence of panic disorder-associated cholecystokinin B receptor allele 7
K Binkley, N King, N Poonai, et al.
Page
of 33